NeuroSense Therapeutics Ltd. Amortisation Expense
NeuroSense Therapeutics Ltd. (NRSN) reported Amortisation Expense of $76.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AmortisationExpense · last filed 2024-04-04
| Period end | Amortisation Expense 6 month | Amortisation Expense 12 month |
|---|---|---|
| 2023-12-31 | $76.00K 20-F · filed 2024-04-04 | |
| 2022-12-31 | $77.00K 20-F · filed 2024-04-04 | |
| 2022-06-30 | $38.00K 6-K/A · filed 2023-01-19 |